2021 ASCO Update on Cardiac Safety of Dual Anti-HER2 Blockade With Pertuzumab + Trastuzumab for HER2+ EBC: APHINITY Trial Data

30 views
June 16, 2021
Comments 0
Login to view comments. Click here to Login